Straumann Holding AGXSWX:STMN -0.42%98 Net Current Asset Value is CHF0.30 as of Dec. 2025, which is 100% below its 10-year median of 273.10. GuruFocus rates XSWX:STMN with a GF Score™ of 98/100 and a GF Value™ of CHF136.92 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 565 Medical Devices & Instruments companies, Straumann Holding AG ranks worse than 99.12% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Straumann Holding AG's net current asset value per share for the quarter that ended in Dec. 2025 was CHF0.30.
The historical rank and industry rank for Straumann Holding AG's Net Current Asset Value or its related term are showing as below:
XSWX:STMN'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 96.56 Med: 273.1 Max: 3975
Current: 354.5
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Straumann Holding AG was 3975.00. The lowest was 96.56. And the median was 273.10.
XSWX:STMN's Price-to-Net-Current-Asset-Value is ranked worse than 99.12% of 565
companies
in the Medical Devices & Instruments industry
Industry Median: 4.93
vs XSWX:STMN: 354.50
Straumann Holding AG (XSWX:STMN) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Straumann Holding AG Net Current Asset Value Related Terms
Straumann Holding AG Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Straumann Holding AG's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Straumann Holding AG Net Current Asset Value Chart
XSWX:STMN vs ISRG, BDX, MDLN: Net Current Asset Value Comparison
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of CHF0.30 mean?
Straumann Holding AG (XSWX:STMN) has a Net Current Asset Value of CHF0.30 as of Dec. 2025. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Straumann Holding AG and its competitors. This is 100% below median its historical median of 273.10. Over the past decade, Straumann Holding AG's Net Current Asset Value has ranged from 96.56 to 3,975.00. According to the industry distribution chart, Straumann Holding AG ranks #560 out of 565 companies in the Medical Devices & Instruments industry, placing it in the top 99.1%.
Is Straumann Holding AG's Net Current Asset Value too high?
Straumann Holding AG's current Net Current Asset Value of CHF0.30 is 100% below median its 10-year median of 273.10. Over the past 10 years, this metric has ranged from a low of 96.56 to a high of 3,975.00. Based on the distribution chart, Straumann Holding AG ranks #560 out of 565 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Straumann Holding AG has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's Net Current Asset Value compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #560 out of 565 companies for Net Current Asset Value. This places Straumann Holding AG in the lower half of its industry. The industry median Net Current Asset Value is 4.93. Historically, Straumann Holding AG's own Net Current Asset Value has ranged from 96.56 to 3,975.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.93, based on 565 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Straumann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Straumann Holding AG's current Net Current Asset Value is CHF0.30, which is 100% below median its own 10-year median of 273.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF136.92, compared to a current price of CHF106.35 — trading 22.3% below its estimated fair value. The current Net Current Asset Value is CHF0.30, which is 100% below median its 10-year median of 273.10. Straumann Holding AG's overall GF Score™ is 98/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current Net Current Asset Value is CHF0.30 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of CHF106.35 is trading 22.3% below its estimated GF Value™ of CHF136.92.
GuruFocus considers Straumann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:STMN:
Net Current Asset Value: CHF0.30 (100% below median its 10-year median of 273.10)
GF Value™: CHF136.92 vs. price of CHF106.35 (22.3% below fair value)
No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
98GF Score
Get the complete analysis for XSWX:STMN
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:STMN has been successfully added to your 
